Enoma 6000 Anti-Xa IU/0.6 ml (SC Injection)

0.6 ml pre-filled syringe: ৳ 500.00

Medicine Details

Category Details
Generic Enoxaparin sodium
Company Biopharma limited
Also available as
Enoma 4000 anti xa injection

Indications

  • Treatment of deep vein thrombosis, with or without pulmonary embolism
  • Treatment of unstable angina and non-Q-wave myocardial infarction
  • Prevention of thrombus formation in the extra-corporal circulation during haemodialysis
  • Prophylaxis of venous thromboembolic disease in surgical patients
  • Prophylaxis of venous thromboembolic disease in medical patients

Composition

  • Enoxaparin Sodium BP 20 mg equivalent to 2000 anti-Xa III
  • Enoxaparin Sodium BP 40 mg equivalent to 4000 anti-Xa III
  • Enoxaparin Sodium BP 60 mg equivalent to 6000 anti-Xa IU
  • Enoxaparin Sodium BP 80 mg equivalent to 8000 anti-Xa IU

Pharmacology

Low molecular weight heparin with high anti-Xa activity

Dosage

  • Subcutaneously 100 anti-Xa lU/kg twice daily for 10 days
  • Oral anticoagulant therapy initiation
  • Subcutaneously 100 anti-Xa lU/kg twice daily for 2- 8 days
  • Recommended dose for prevention of thrombus formation in extra corporeal circulation
  • Subcutaneously 2000 anti-Xa IU (0.2 ml) or 4000 anti-Xa IU (0.4 ml) once daily for 7 to 10 days
  • Subcutaneously 4000 anti-Xa IU (0.4 ml) once daily for 7 to 10 days

Administration

  • Injection site preparation instructions
  • Dosage selection guidelines
  • Injection technique instructions
  • Post-injection care instructions

Interaction

Recommended discontinuation of agents affecting hemostasis prior to therapy

Contraindications

Hypersensitivity to Enoxaparin Sodium, active major bleeding

Side Effects

  • Haemorrhage (bleeding)
  • Thrombocytopenia
  • Elevations of serum aminotransferase
  • Skin reactions at injection sites

Pregnancy & Lactation

Pregnancy category B. Use only if clearly needed. Consideration for nursing mothers.

Precautions & Warnings

  • Deep subcutaneous route administration
  • Caution in conditions with increased potential for bleeding
  • Platelet count monitoring recommendation

Use in Special Populations

  • Dose adjustment considerations for elderly patients
  • Renal impairment dose adjustments
  • Caution in hepatically impaired patients

Overdose Effects

Accidental overdosage may lead to hemorrhagic complications

Therapeutic Class

Parenteral anti-coagulants

Storage Conditions

Cool and dry place, protect from light and moisture, below 25°C, keep out of reach of children

Related Brands